Bioxytran, Inc.
BIXT · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6,318 | $9,310 | $1 | $12,460 |
| - Cash | $14 | $3 | $4 | $5 |
| + Debt | $855 | $1,345 | $1,261 | $1,094 |
| Enterprise Value | $7,159 | $10,653 | $1,258 | $13,549 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$3 | -$2 | -$3 |
| % Margin | – | – | – | – |
| EBITDA | -$242 | $83 | -$1,320 | -$484 |
| % Margin | – | – | – | – |
| Net Income | -$283 | $35 | -$1,354 | -$512 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.003 | 0 | -152.37 | -0.004 |
| % Growth | -900% | 100% | -3,809,150% | – |
| Operating Cash Flow | -$41 | -$81 | -$167 | $42 |
| Capital Expenditures | $15 | -$15 | $0 | -$10 |
| Free Cash Flow | -$26 | -$96 | -$167 | $32 |